ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q3Scopus Q2SCImago #10,720Hybrid

Diagnostic Microbiology and Infectious Disease

Acronym:dmid
•
Abbreviation (ISO):DIAGN MICR INFEC DIS
•
Identifier (ISSN):0732-8893(Print)/1879-0070(Online)
•
Publisher:Elsevier Inc.
Clarivate IF (2026)
1.8– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q3
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Diagnostic Microbiology and Infectious Disease

WoS Q3
12342.3420182.3120192.520202.820212.9820222.920232.120241.820251.82026
Annual Impact Factor Metric
Current (2026):1.8
Scopus SJR & RankScopus Q2
0.553
#10,720

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
111

111 papers with at least that number of citations each

WoS: SCIE / JCRQ3
Self-Citation Rate4.8%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
251articles/year
25.05% Gold OA•97.44% Original Research

Aims & Scope

Diagnostic Microbiology and Infectious Disease keeps you informed of the latest developments in clinical microbiology and the diagnosis and treatment of infectious diseases. Packed with rigorously peer-reviewed articles and studies in bacteriology, immunology, immunoserology, infectious diseases, mycology, parasitology, and virology, the journal examines new procedures, unusual cases, controversial issues, and important new literature. Diagnostic Microbiology and Infectious Disease distinguished independent editorial board, consisting of experts from many medical specialties, ensures you extensive and authoritative coverage.

Topics Covered (Recognized by AI)
Biology96%Genetics90.2%Medicine83.8%Chemistry79.7%Biochemistry77.5%Microbiology76.6%Geology60.5%Paleontology60.4%Bacteria57.1%Antibiotics48.9%Internal medicine42.9%Gene42%Immunology36.7%Pathology35.1%Virology32.6%Organic chemistry28.1%Antimicrobial20.7%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

INFECTIOUS DISEASES

Q3
Rank105/141
IndexSCIE
JCRSCIE2026

MICROBIOLOGY

Q4
Rank143/167
IndexSCIE
JCISCIE2026

INFECTIOUS DISEASES

Q3
Rank101/141
IndexSCIE
JCISCIE2026

MICROBIOLOGY

Q4
Rank129/167
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF1.8
Articles / Year352
Total Citations85
2025
IF1.8
Articles / Year477
Total Citations787
2024
IF2.1
Articles / Year408
Total Citations1,483
2023
IF2.9
Articles / Year188
Total Citations1,181
2022
IF2.983
Articles / Year146
Total Citations1,221

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #10,720Scopus Q2SCImago Profile
Scopus Coverage:1983-2026
Scopus Broad Areas:Medicine
Scopus Citation Rank (SJR)Q2
0.553

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
1.99

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,086 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,320
3-Year Documents684
Citable Documents671

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)1

Citations in government and international policy documents

Female Author Rate48.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2
Infectious DiseasesQ3
Microbiology (medical)Q3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
4区 (Zone 4)Medicine
Minor Category (Specific Field):
4区INFECTIOUS DISEASES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Diagnostic Microbiology and Infectious Disease (acronym: dmid, abbr: DIAGN MICR INFEC DIS, ISSN: 0732-8893) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Inc. in United States since 1983. The periodical holds a Journal Impact Factor (JIF) of 1.80, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.553 (Q2), an H-index of 111.

The journal enforces rigorous peer evaluation with an average review speed of 5.9周, a publication frequency of Monthly, an annual output of approximately 251 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,086 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier Inc.
Publication Language
English
Frequency
Monthly
Founding Year
1983
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, USA, NY, 10010-1710

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 7f9ec56a-1307-4cc4-808a-2e1186cba32f
Database Updated: 2026-10-16